Moreover, accumulating observational clinical data in IBD and other immune mediated inflammatory diseases (IMIDs) have highlighted the potential benefit of anti-TNF therapies as treatment for COVID-19 and have also led to initiation of various clinical trials that are currently investigating use of anti-TNF in COVID-19 [25]. Here, TNF is linked to inflammatory bowel disease.